-
公开(公告)号:EP4423109A1
公开(公告)日:2024-09-04
申请号:EP21962739.5
申请日:2021-12-22
Applicant: Plasma Technologies LLC
Inventor: ZURLO, Eugene , CURTIN, Dennis , RADTKE, Klaus Peter , DORFMAN, Ryan , WHELIHAN, Matthew
CPC classification number: B01D15/362 , B01D15/363 , C07K1/18 , B01D15/3847 , B01D15/1871 , B01D15/3809 , C07K1/16 , B01D15/327
-
公开(公告)号:EP3439780B1
公开(公告)日:2024-07-03
申请号:EP17714436.7
申请日:2017-03-30
IPC: B01J20/32 , B01J20/286 , B01D15/38 , B01J20/26 , B01J20/289
CPC classification number: B01D15/3804 , B01J20/267 , B01J20/286 , B01J20/289 , B01J20/3208 , B01J20/3217 , B01J20/3219 , B01J20/3278 , B01J20/3285 , B01J20/3293 , B01J2220/5420130101 , B01D15/327 , B01D15/361 , B01D15/3847 , B01D15/362 , B01D15/363 , B01D15/3809 , B01J39/26 , B01J41/20 , B01J47/02
-
公开(公告)号:EP3397386B1
公开(公告)日:2024-06-19
申请号:EP16882337.5
申请日:2016-12-16
IPC: B01D15/36 , B01J41/07 , B01J39/05 , B01J39/07 , B01J39/18 , B01J41/12 , B01J47/04 , C07C67/56 , C07C69/14
CPC classification number: C07C67/56 , B01J41/07 , B01D15/00 , B01J47/04 , B01D15/362 , B01D15/363 , B01J39/18 , B01J41/12
-
4.
公开(公告)号:EP4370228A1
公开(公告)日:2024-05-22
申请号:EP22782777.1
申请日:2022-07-11
Applicant: Donaldson Company, Inc.
Inventor: ZHOU, Jinxiang , TEMPLES, Graham , GUO, Bin
IPC: B01D15/36 , B01D15/32 , B01D15/38 , B01J20/28 , C07K1/16 , C12N15/10 , B01J41/20 , B01J47/12 , C07K1/18
CPC classification number: B01D15/363 , B01D15/362 , B01D15/322 , B01D15/327 , B01D15/3847 , C12N15/101 , B01D69/147 , B01D2325/1620130101 , B01D2325/1420130101 , B01D2325/3620130101 , B01D2325/3820130101 , B01D69/02 , B01D67/00931
-
公开(公告)号:EP4351755A1
公开(公告)日:2024-04-17
申请号:EP22821261.9
申请日:2022-06-10
Applicant: Spark Therapeutics, Inc.
Inventor: KHANAL, Ohnmar , KUMAR, Vijesh , JIN, Mi
CPC classification number: C12N15/86 , C12N2750/1414320130101 , C12N2750/1415120130101 , B01D15/363 , B01D15/422
-
公开(公告)号:EP2914612B1
公开(公告)日:2018-11-14
申请号:EP13794828.7
申请日:2013-10-28
Applicant: F. Hoffmann-La Roche AG
Inventor: BECKER, Peter , NEUMANN, Sebastian
IPC: C07K1/34
CPC classification number: C07K1/34 , B01D15/362 , B01D15/363 , B01D61/145 , B01D2315/10 , B01D2317/02 , C07K1/36 , C12M47/10 , C12M47/12
Abstract: The present invention is directed to methods for the separation of a molecule of interest from a solution containing the molecule using dual stage tangential-flow ultrafiltration (“TFF”). In particular, the methods of the invention are directed to the processing of crude feed streams such as conditioned cell culture supernatant to dramatically reduce contaminant and/or impurity levels prior to subsequent, i.e., downstream, refining unit operations. The methods of the invention may be used in the processing of a crude feed stream from biological production systems such as fermentation or other cell culture process, and may further eliminate the need for time consuming impurity precipitation (e.g., pH driven) and/or precipitate filtration processes prior to downstream processes that are sensitive to high impurity loads such as chromatographic unit operations. The disclosed dual stage TFF process combines at least two TFF unit operations that may be advantageously conducted at a pH that corresponds to or is about that of the pH of the feed stream, e.g., a cell culture supernatant, typically a pH of 7.5±1.0. The use of the TFF unit operations to supplement, improve or replace traditional processes for purification of proteins of interest for a feed stream may represent significant savings in both direct and indirect processing costs, For example, in addition to indirect savings by eliminating precipitation and precipitate filtration processes, the reduction in impurity loads effected by the dual stage TFF unit operations may result in indirect savings by improving downstream column performance, e.g., chromatographic separation, dynamic binding capacity, operational lifetime and/or a reduction of the required column size. In particular embodiments, the methods of the invention are used in processes for the purification of immunoglobulin molecules, e.g., antibodies, which processes are devoid of affinity purification steps, e.g., protein A affinity chromatography purification.
-
公开(公告)号:EP2814608B1
公开(公告)日:2018-11-14
申请号:EP13748604.9
申请日:2013-02-08
Applicant: Bio-Rad Laboratories, Inc.
Inventor: GAGNON, Peter S.
CPC classification number: G01N1/34 , B01D15/20 , B01D15/327 , B01D15/362 , B01D15/363 , B01D15/3847 , B01D15/422 , G01N30/96 , Y10T436/25375
Abstract: Provided are methods and compositions for reducing or eliminating pH excursions in cation and anion exchange chromatography.
-
公开(公告)号:EP2748178B1
公开(公告)日:2018-10-31
申请号:EP12748689.2
申请日:2012-08-17
Applicant: F. Hoffmann-La Roche AG
Inventor: FALKENSTEIN, Roberto , MAGRI, Maria, Laura , MEHR, Michaela , SCHWENDNER, Klaus , SPENSBERGER, Bernhard
IPC: C07K1/18
CPC classification number: C07K14/775 , B01D15/362 , B01D15/363 , C07K1/18
Abstract: Herein is reported a method for purifying a polypeptide comprising the steps of i) applying a solution comprising the polypeptide to an ion exchange chromatography material, and ii) recovering the polypeptide with a solution comprising a denaturant and thereby purifying the polypeptide, whereby the ion exchange chromatography material comprises a matrix of cross-linked poly (styrene-divinylbenzene) to which ionic ligands have been attached, and wherein the solution comprising the polypeptide applied to the ion exchange chromatography material is free of the denaturant and the polypeptide adsorbed to the ion exchange chromatography material is recovered with a solution comprising a denaturant at a constant conductivity.
-
公开(公告)号:EP3377514A1
公开(公告)日:2018-09-26
申请号:EP16788430.3
申请日:2016-10-28
Applicant: Merck Patent GmbH
Inventor: JOEHNCK, Matthias
CPC classification number: C07K1/18 , B01D15/362 , B01D15/363 , B01D15/3809 , B01D15/3847 , B01D15/388 , B01D15/424 , C07K1/165 , C07K16/00 , C07K2317/52 , C07K2317/55 , C07K2317/56
Abstract: The present invention relates to a method for an improved preparative separation of proteins, particularly monoclonal antibodies (mAB) from its associated charge variants (e. g. acidic and basic monomers), glycosylation variants, and/or soluble size variants (e. g. aggregates, monomers, ⅔ fragments, ¾ fragments, antigen binding fragments (Fab) and crystallisable fragments (Fc).
-
公开(公告)号:EP2745903B1
公开(公告)日:2018-09-19
申请号:EP13198648.1
申请日:2013-12-19
Applicant: Dionex Corporation
Inventor: LIU, Xiaodong , AICH, Udayanath , POHL, Christopher A.
CPC classification number: C08B37/0063 , B01D15/3847 , B01J20/286 , B01J20/3285 , B01J41/20 , B01J43/00 , B01J2220/54 , C07K1/165 , G01N30/482 , B01D15/363 , B01D15/305 , B01D15/325 , B01D15/362
Abstract: An exemplary multimodal chromatographic medium of the invention includes one or more strong anion exchange, weak anion exchange, strong cation exchange and/or weak cation exchange binding sites in combination with one or more reverse phase and/or hydrophilic interaction chromatography binding site. In an exemplary embodiment, the sites interact with one or more glycans in a mixture of glycans in a manner that allows separation of glycans in the mixture and analysis of the glycan mixture. The media are incorporated into devices and systems for chromatographic analysis. Also provided are methods of using the multimodal media of the invention to analyze glycans.
-
-
-
-
-
-
-
-
-